Occult hepatitis B virus among chronic liver disease patients in Yemen

A. M. Thabit, K. A. Al-Moyed, M. S. Al-Balushi, S. S. Hasson, T. A. Sallam

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: To estimate the rate of occult hepatitis B virus (HBV) among patients with chronic liver disease (CLD). Methods: After an informed consent, sera samples were collected during April 2004 to April 2005 from 280 patients (200 male and 80 female). They were previously diagnosed with CLD based on history and ultrasound and were investigated for occult HBV infection. Sera were first screened for HBsAg and those which showed negative were tested for anti-HBc. The anti-HBc positive sera were further tested for anti-HBs to identify sera with isolated anti-HBc which in turn were subjected to HBV-DNA testing using PCR to determine the rate of occult HBV infection. Moreover, sera with occult HBV were tested for Anti-HCV and HCV-RNA using RT-PCR. Results: HBsAg was detected in 44 of 280 (15.7%). Of 236 HBsAg negative sera anti-HBc was detected in 22 (9.3%). All anti-HBc positive sera were found to be anti-HBs negative. HBV-DNA was detected in 11 of 22 (50.0%) sera with isolated anti-HBc indicating occult HBV in 4.3% of all sera. None of the sera with occult HBV had anti-HCV or HCV-RNA. Conclusions: Occult HBV infection does exist among CLD patients in Yemen and the mechanism of its occurrence merits further investigation.

Original languageEnglish
Pages (from-to)4-6
Number of pages3
JournalAsian Pacific Journal of Tropical Disease
Volume2
Issue number1
DOIs
Publication statusPublished - Feb 2012

Fingerprint

Yemen
Hepatitis B virus
Liver Diseases
Chronic Disease
Serum
Virus Diseases
Hepatitis B Surface Antigens
RNA
Polymerase Chain Reaction
DNA
Informed Consent
History

Keywords

  • Chronic liver disease
  • HBsAg
  • HBV-DNA
  • Hepatitis B virus

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)

Cite this

Occult hepatitis B virus among chronic liver disease patients in Yemen. / Thabit, A. M.; Al-Moyed, K. A.; Al-Balushi, M. S.; Hasson, S. S.; Sallam, T. A.

In: Asian Pacific Journal of Tropical Disease, Vol. 2, No. 1, 02.2012, p. 4-6.

Research output: Contribution to journalArticle

@article{f005ec38851d4f1192cb2aa24dc1e152,
title = "Occult hepatitis B virus among chronic liver disease patients in Yemen",
abstract = "Objective: To estimate the rate of occult hepatitis B virus (HBV) among patients with chronic liver disease (CLD). Methods: After an informed consent, sera samples were collected during April 2004 to April 2005 from 280 patients (200 male and 80 female). They were previously diagnosed with CLD based on history and ultrasound and were investigated for occult HBV infection. Sera were first screened for HBsAg and those which showed negative were tested for anti-HBc. The anti-HBc positive sera were further tested for anti-HBs to identify sera with isolated anti-HBc which in turn were subjected to HBV-DNA testing using PCR to determine the rate of occult HBV infection. Moreover, sera with occult HBV were tested for Anti-HCV and HCV-RNA using RT-PCR. Results: HBsAg was detected in 44 of 280 (15.7{\%}). Of 236 HBsAg negative sera anti-HBc was detected in 22 (9.3{\%}). All anti-HBc positive sera were found to be anti-HBs negative. HBV-DNA was detected in 11 of 22 (50.0{\%}) sera with isolated anti-HBc indicating occult HBV in 4.3{\%} of all sera. None of the sera with occult HBV had anti-HCV or HCV-RNA. Conclusions: Occult HBV infection does exist among CLD patients in Yemen and the mechanism of its occurrence merits further investigation.",
keywords = "Chronic liver disease, HBsAg, HBV-DNA, Hepatitis B virus",
author = "Thabit, {A. M.} and Al-Moyed, {K. A.} and Al-Balushi, {M. S.} and Hasson, {S. S.} and Sallam, {T. A.}",
year = "2012",
month = "2",
doi = "10.1016/S2222-1808(12)60002-4",
language = "English",
volume = "2",
pages = "4--6",
journal = "Asian Pacific Journal of Tropical Disease",
issn = "2222-1808",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Occult hepatitis B virus among chronic liver disease patients in Yemen

AU - Thabit, A. M.

AU - Al-Moyed, K. A.

AU - Al-Balushi, M. S.

AU - Hasson, S. S.

AU - Sallam, T. A.

PY - 2012/2

Y1 - 2012/2

N2 - Objective: To estimate the rate of occult hepatitis B virus (HBV) among patients with chronic liver disease (CLD). Methods: After an informed consent, sera samples were collected during April 2004 to April 2005 from 280 patients (200 male and 80 female). They were previously diagnosed with CLD based on history and ultrasound and were investigated for occult HBV infection. Sera were first screened for HBsAg and those which showed negative were tested for anti-HBc. The anti-HBc positive sera were further tested for anti-HBs to identify sera with isolated anti-HBc which in turn were subjected to HBV-DNA testing using PCR to determine the rate of occult HBV infection. Moreover, sera with occult HBV were tested for Anti-HCV and HCV-RNA using RT-PCR. Results: HBsAg was detected in 44 of 280 (15.7%). Of 236 HBsAg negative sera anti-HBc was detected in 22 (9.3%). All anti-HBc positive sera were found to be anti-HBs negative. HBV-DNA was detected in 11 of 22 (50.0%) sera with isolated anti-HBc indicating occult HBV in 4.3% of all sera. None of the sera with occult HBV had anti-HCV or HCV-RNA. Conclusions: Occult HBV infection does exist among CLD patients in Yemen and the mechanism of its occurrence merits further investigation.

AB - Objective: To estimate the rate of occult hepatitis B virus (HBV) among patients with chronic liver disease (CLD). Methods: After an informed consent, sera samples were collected during April 2004 to April 2005 from 280 patients (200 male and 80 female). They were previously diagnosed with CLD based on history and ultrasound and were investigated for occult HBV infection. Sera were first screened for HBsAg and those which showed negative were tested for anti-HBc. The anti-HBc positive sera were further tested for anti-HBs to identify sera with isolated anti-HBc which in turn were subjected to HBV-DNA testing using PCR to determine the rate of occult HBV infection. Moreover, sera with occult HBV were tested for Anti-HCV and HCV-RNA using RT-PCR. Results: HBsAg was detected in 44 of 280 (15.7%). Of 236 HBsAg negative sera anti-HBc was detected in 22 (9.3%). All anti-HBc positive sera were found to be anti-HBs negative. HBV-DNA was detected in 11 of 22 (50.0%) sera with isolated anti-HBc indicating occult HBV in 4.3% of all sera. None of the sera with occult HBV had anti-HCV or HCV-RNA. Conclusions: Occult HBV infection does exist among CLD patients in Yemen and the mechanism of its occurrence merits further investigation.

KW - Chronic liver disease

KW - HBsAg

KW - HBV-DNA

KW - Hepatitis B virus

UR - http://www.scopus.com/inward/record.url?scp=84856865424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856865424&partnerID=8YFLogxK

U2 - 10.1016/S2222-1808(12)60002-4

DO - 10.1016/S2222-1808(12)60002-4

M3 - Article

VL - 2

SP - 4

EP - 6

JO - Asian Pacific Journal of Tropical Disease

JF - Asian Pacific Journal of Tropical Disease

SN - 2222-1808

IS - 1

ER -